Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • SUR mutation in type 1 diabete...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
SUR mutation in type 1 diabetes: autoimmunity prevents sulfonylurea rescue of diabetes caused by SUR1 mutation. Results from the Hvidore Study Group

SUR mutation in type 1 diabetes: autoimmunity prevents sulfonylurea rescue of diabetes caused by SUR1 mutation. Results from the Hvidore Study Group

Bibliographic Details
Main Authors: Porksen, S, Laborie, L, Nielsen, L, De Wet, H, Schvarcz, E, Sandal, T, Aman, J, Swift, P, Hougaard, P, Ashcroft, F, Molven, A, Knip, M, Hansen, L, Njolstad, P, Mortensen, H
Format: Conference item
Published: 2008
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • Disease progression and search for monogenic diabetes among children with new onset type 1 diabetes negative for ICA, GAD- and IA-2 Antibodies
    by: Pörksen, S, et al.
    Published: (2010)
  • Disease progression and search for monogenic diabetes among children with new onset type 1 diabetes negative for ICA, GAD- and IA-2 Antibodies
    by: de Beaufort Carine, et al.
    Published: (2010-09-01)
  • Kir6.2 mutations causing neonatal diabetes provide new insights into Kir6.2-SUR1 interactions.
    by: Tammaro, P, et al.
    Published: (2005)
  • Functional effects of mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), causing neonatal diabetes, and response to sulfonylurea therapy.
    by: Proks, P, et al.
    Published: (2006)
  • Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.
    by: Pearson, E, et al.
    Published: (2006)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs